| Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations J Grau-Expósito, L Luque-Ballesteros, J Navarro, A Curran, J Burgos, ... PLoS pathogens 15 (8), e1007991, 2019 | 143 | 2019 |
| Current and potential usefulness of pneumococcal urinary antigen detection in hospitalized patients with community-acquired pneumonia to guide antimicrobial therapy R Sordé, V Falcó, M Lowak, E Domingo, A Ferrer, J Burgos, M Puig, ... Archives of internal medicine 171 (2), 166-172, 2011 | 139 | 2011 |
| Peripheral and lung resident memory T cell responses against SARS-CoV-2 J Grau-Expósito, N Sánchez-Gaona, N Massana, M Suppi, ... Nature communications 12 (1), 3010, 2021 | 131 | 2021 |
| Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised … WH Self, U Sandkovsky, CS Reilly, DM Vock, RL Gottlieb, M Mack, ... The Lancet Infectious Diseases 22 (5), 622-635, 2022 | 124 | 2022 |
| Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29 900 men according to HIV status, sexuality, and age: a collaborative … F Wei, MM Gaisa, G D'Souza, N Xia, AR Giuliano, SE Hawes, L Gao, ... The Lancet HIV 8 (9), e531-e543, 2021 | 105 | 2021 |
| A Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4+ T cells as a Major Niche for HIV-1 Transcription in HIV-Infected Patients J Grau-Expósito, C Serra-Peinado, L Miguel, J Navarro, A Curran, ... MBio 8 (4), 10.1128/mbio. 00876-17, 2017 | 100 | 2017 |
| Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study DK Nomah, J Reyes-Urueña, Y Díaz, S Moreno, J Aceiton, A Bruguera, ... The Lancet HIV 8 (11), e701-e710, 2021 | 99 | 2021 |
| The increasing incidence of empyema J Burgos, V Falcó, A Pahissa Current opinion in pulmonary medicine 19 (4), 350-356, 2013 | 97 | 2013 |
| Body composition changes after switching from protease inhibitors to raltegravir: SPIRAL-LIP substudy A Curran, E Martinez, M Saumoy, L Del Rio, M Crespo, M Larrousse, ... AIDS 26 (4), 475-481, 2012 | 83 | 2012 |
| The spectrum of pneumococcal empyema in adults in the early 21st century J Burgos, M Lujan, V Falco, A Sánchez, M Puig, A Borrego, D Fontanals, ... Clinical infectious diseases 53 (3), 254-261, 2011 | 77 | 2011 |
| Risk of progression to high-grade anal intraepithelial neoplasia in HIV-infected MSM J Burgos, A Curran, N Tallada, A Guelar, J Navarro, S Landolfi, J Villar, ... Aids 29 (6), 695-702, 2015 | 65 | 2015 |
| Tropical diseases screening in immigrant patients with human immunodeficiency virus infection in Spain F Salvador, I Molina, E Sulleiro, J Burgos, A Curran, E Van den Eynde, ... The American journal of tropical medicine and hygiene 88 (6), 1196, 2013 | 62 | 2013 |
| Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes J Burgos, M Luján, MN Larrosa, D Fontanals, G Bermudo, AM Planes, ... European Respiratory Journal 43 (2), 545-553, 2014 | 58 | 2014 |
| Levofloxacin versus azithromycin for treating legionella pneumonia: a propensity score analysis C Garcia-Vidal, I Sanchez-Rodriguez, AF Simonetti, J Burgos, D Viasus, ... Clinical Microbiology and Infection 23 (9), 653-658, 2017 | 53 | 2017 |
| Effects of immunocompromise and comorbidities on pneumococcal serotypes causing invasive respiratory infection in adults: implications for vaccine strategies M Luján, J Burgos, M Gallego, V Falcó, G Bermudo, A Planes, ... Clinical infectious diseases 57 (12), 1722-1730, 2013 | 51 | 2013 |
| Expression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab C Serra-Peinado, J Grau-Expósito, L Luque-Ballesteros, ... Nature communications 10 (1), 3705, 2019 | 50 | 2019 |
| Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort JM Llibre, A Montoliu, JM Miró, P Domingo, M Riera, J Tiraboschi, ... HIV medicine 20 (3), 237-247, 2019 | 49 | 2019 |
| Impact of the emergence of non-vaccine pneumococcal serotypes on the clinical presentation and outcome of adults with invasive pneumococcal pneumonia J Burgos, V Falcó, A Borrego, R Sordé, MN Larrosa, X Martinez, ... Clinical microbiology and infection 19 (4), 385-391, 2013 | 47 | 2013 |
| The effectiveness of electrocautery ablation for the treatment of high‐grade anal intraepithelial neoplasia in HIV‐infected men who have sex with men J Burgos, A Curran, S Landolfi, J Navarro, N Tallada, A Guelar, M Crespo, ... HIV medicine 17 (7), 524-531, 2016 | 45 | 2016 |
| The role of oncogenic human papillomavirus determination for diagnosis of high-grade anal intraepithelial neoplasia in HIV-infected MSM J Burgos, J Hernández-Losa, S Landolfi, A Guelar, MC Dinares, J Villar, ... Aids 31 (16), 2227-2233, 2017 | 43 | 2017 |
